Clinical Trial Update: Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing eltrombopag for delayed post-transplant thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Thrombocytopenia | Phase 2 | Status: COMPLETED